These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9036963)
1. Both resting and activated B lymphocytes expressing engineered peptide-Ig molecules serve as highly efficient tolerogenic vehicles in immunocompetent adult recipients. Zambidis ET; Barth RK; Scott DW J Immunol; 1997 Mar; 158(5):2174-82. PubMed ID: 9036963 [TBL] [Abstract][Full Text] [Related]
2. Genetically transferred central and peripheral immune tolerance via retroviral-mediated expression of immunogenic epitopes in hematopoietic progenitors or peripheral B lymphocytes. Zambidis ET; Kurup A; Scott DW Mol Med; 1997 Mar; 3(3):212-24. PubMed ID: 9100227 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of tolerance induction by a gene-transferred peptide-IgG fusion protein expressed in B lineage cells. El-Amine M; Melo M; Kang Y; Nguyen H; Qian J; Scott DW J Immunol; 2000 Nov; 165(10):5631-6. PubMed ID: 11067919 [TBL] [Abstract][Full Text] [Related]
4. In vivo induction of tolerance by an Ig peptide is not affected by the deletion of FcR or a mutated IgG Fc fragment. el-Amine M; Hinshaw JA; Scott DW Int Immunol; 2002 Jul; 14(7):761-6. PubMed ID: 12096035 [TBL] [Abstract][Full Text] [Related]
5. Tolerance induction via a B-cell delivered gene therapy-based protocol: optimization and role of the Ig scaffold. Lei TC; Su Y; Scott DW Cell Immunol; 2005 May; 235(1):12-20. PubMed ID: 16098495 [TBL] [Abstract][Full Text] [Related]
6. Epitope-specific tolerance induction with an engineered immunoglobulin. Zambidis ET; Scott DW Proc Natl Acad Sci U S A; 1996 May; 93(10):5019-24. PubMed ID: 8643522 [TBL] [Abstract][Full Text] [Related]
7. Induction of hyporesponsiveness to intact foreign protein via retroviral-mediated gene expression: the IgG scaffold is important for induction and maintenance of immune hyporesponsiveness. Kang Y; Melo M; Deng E; Tisch R; El-Amine M; Scott DW Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8609-14. PubMed ID: 10411923 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of gene therapy for tolerance: B7 signaling is required for peptide-IgG gene-transferred tolerance induction. Litzinger MT; Su Y; Lei TC; Soukhareva N; Scott DW J Immunol; 2005 Jul; 175(2):780-7. PubMed ID: 16002674 [TBL] [Abstract][Full Text] [Related]
9. Coexpression of B7-1 and antigen blocks tolerance induction to antigen presented by resting B cells. Yuschenkoff VN; Sethna MP; Freeman GJ; Parker DC J Immunol; 1996 Sep; 157(5):1987-95. PubMed ID: 8757319 [TBL] [Abstract][Full Text] [Related]
10. Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis. Agarwal RK; Kang Y; Zambidis E; Scott DW; Chan CC; Caspi RR J Clin Invest; 2000 Jul; 106(2):245-52. PubMed ID: 10903340 [TBL] [Abstract][Full Text] [Related]
11. Presence of activated antigen-binding B cells during immunization enhances relative levels of IFN-gamma in T cell responses. Pasare C; Morafo V; Entringer M; Bansal P; George A; Bal V; Rath S; Durdik JM J Immunol; 1998 Jan; 160(2):778-87. PubMed ID: 9551913 [TBL] [Abstract][Full Text] [Related]
12. Polyclonal activation of the murine immune system by an antibody to IgD. VII. Demonstration of the role of nonantigen-specific T help in in vivo B cell activation. Finkelman FD; Smith J; Villacreses N; Metcalf ES J Immunol; 1984 Aug; 133(2):550-5. PubMed ID: 6203966 [TBL] [Abstract][Full Text] [Related]
13. Rapid induction of autoantibodies by endogenous ovarian antigens and activated T cells: implication in autoimmune disease pathogenesis and B cell tolerance. Lou YH; McElveen MF; Garza KM; Tung KS J Immunol; 1996 May; 156(9):3535-40. PubMed ID: 8617983 [TBL] [Abstract][Full Text] [Related]
14. Anergic B cells constitutively present self antigen: enhanced immunoglobulin receptor-mediated presentation of antigenic determinants by B cells is hierarchical. Kanost D; McCluskey J Eur J Immunol; 1994 May; 24(5):1186-93. PubMed ID: 7514133 [TBL] [Abstract][Full Text] [Related]
15. Non-tolerant B cells cause autoimmunity in anti-CD8 IgG2a-transgenic mice. Battegay M; Fiedler P; Kalinke U; Brombacher F; Zinkernagel RM; Peter HH; Köhler G; Eibel H Eur J Immunol; 1996 Jan; 26(1):250-8. PubMed ID: 8566075 [TBL] [Abstract][Full Text] [Related]
16. Priming of helper T cell-dependent antibody responses by hemagglutinin-transgenic B cells. Kalberer CP; Reininger L; Melchers F; Rolink AG Eur J Immunol; 1997 Sep; 27(9):2400-7. PubMed ID: 9341786 [TBL] [Abstract][Full Text] [Related]
17. Reduction of early B lymphocyte precursors in transgenic mice overexpressing the murine heat-stable antigen. Hough MR; Chappel MS; Sauvageau G; Takei F; Kay R; Humphries RK J Immunol; 1996 Jan; 156(2):479-88. PubMed ID: 8543797 [TBL] [Abstract][Full Text] [Related]
18. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain. Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392 [TBL] [Abstract][Full Text] [Related]
19. Gene transfer of Ig-fusion proteins into B cells prevents and treats autoimmune diseases. Melo ME; Qian J; El-Amine M; Agarwal RK; Soukhareva N; Kang Y; Scott DW J Immunol; 2002 May; 168(9):4788-95. PubMed ID: 11971030 [TBL] [Abstract][Full Text] [Related]
20. Immunogenic properties of an anti-DNA antibody-derived peptide, 88H.64-80: location of a dominant idiotope defined by T and B cells. Ward FJ; Khan N; Wolger LJ; Howe CA; Eivazova ER; Harper N; Muller S; Staines NA J Autoimmun; 1998 Oct; 11(5):439-47. PubMed ID: 9802927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]